Association of Maternal and Paternal Depression in the Postnatal Period With Offspring Depression at Age 18 Years.

Importance: Paternal depression during the postnatal period has been associated with adverse child outcomes. Family environment has been reported as a pathway for risk transmission from fathers to children. The influence of paternal depression during the postnatal period on offspring depression remains to be clarified. Objective: To investigate the association between paternal depression in the postnatal period and offspring depression and explore potential mediating and moderating factors that influence any association between paternal and offspring depression. Design, Setting, and Participants: This prospective study of a UK community-based birth cohort (the Avon Longitudinal Study of Parents and Children) of parents and their adolescent offspring investigated associations between paternal depression during the postnatal period and offspring depression at age 18 years. We tested a hypothesized moderator (ie, sex) and conducted path analysis to examine hypothesized mediators (ie, depression in the other parent, couple conflict, and paternal involvement and emotional problems, conduct problems, and hyperactivity in offspring at age 3.5 years) of the associations between both paternal and maternal depression and offspring depression. Data collection for the Avon Longitudinal Study of Parents and Children began in 1991 and is ongoing. Data analysis for this study was conducted from June 2015 to September 2018. Exposures: Depression symptoms in fathers at 8 weeks after the birth of their children. Main Outcomes and Measures: Offspring depression symptoms at age 18 years, using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes. Results: A total of 3176 father-offspring pairs were analyzed; of the children, 1764 were girls (55.5%) and 1412 (44.5%) were boys. Paternal mean (SD) age at delivery was 29.6 (9.6) years. The offspring of fathers who had depression during the postnatal period were at increased risk of experiencing depression symptoms at age 18 years (ß = 0.053 [95% CI, 0.02-0.09]). The association is mediated by maternal depression at 8 months after birth (ß = 0.011 [95% CI, 0.0008-0.02]; 21% [0.011/0.053]) and conduct problems at 42 months after birth (ß = 0.004; [95% CI , -0.00004 to 0.009]; 7.5% [0.004/0.053]). Couple conflict and paternal involvement do not mediate this association. The increased risk is seen in girls but not boys (interaction ß = 0.095; P = .01). Conclusions and Relevance: The association between paternal depression in the postnatal period and depression in girls at age 18 years is partially explained by maternal depression. Couple conflict and paternal involvement were not found to play a role in the risk of transmission; this contrasts with the role that couple conflict was found to play in the risk of childhood behavior problems. Conduct problems in childhood appear to be a pathway for risk transmission between paternal depression and subsequent depression in offspring at age 18 years.

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis.

Background: We aimed to investigate the state of cardiovascular risk/protection factors in early psychosis patients. Methods: A total 119 subjects were recruited during the first year after their first episode of psychosis. Eighty-five of these subjects were followed during the next 6 months. Cardiovascular risk/protection factors were measured in plasma and co-variated by sociodemographic/clinical characteristics. Multiple linear regression models detected the change of each biological marker from baseline to follow-up in relation to clinical scales, antipsychotic medication, and pro-/antiinflammatory mediators. Results: Glycosylated hemoglobin is a state biomarker in first episode of psychosis follow-up patients and inversely correlated to the Global Assessment of Functioning scale. We found opposite alterations in the levels of VCAM-1 and E-selectin in first episode of psychosis baseline conditions compared with control that were absent in the first episode of psychosis follow-up group. Adiponectin levels decreased in a continuum in both pathological time points studied. E-Selectin plasma levels were inversely related to total antipsychotic equivalents and adiponectin levels inversely co-related to the Global Assessment of Functioning scale. Finally, adiponectin levels were directly related to antiinflammatory nuclear receptor PPARγ expression in first episode of psychosis baseline conditions and to proinflammatory nuclear factor nuclear factor κB activity in follow-up conditions, respectively. Conclusions: Our results support the need for integrating cardiovascular healthcare very early after the first episode of psychosis.

Paternal depression in the postnatal period and child development: mediators and moderators.

OBJECTIVE: To explore potential mediating and moderating factors that influence the association between paternal depression in the postnatal period and subsequent child behavioral and emotional problems. METHODS: A population-based cohort (N = 13,822) from the Avon Longitudinal Study of Parents and Children (ALSPAC) was recruited during pregnancy. Paternal and maternal depressive symptoms were assessed with the Edinburgh Postnatal Depression Scale at 8 weeks after the birth of the child. Child outcomes were assessed at 3.5 years by using the Rutter revised preschool scales and at 7 years by using the Strengths and Difficulties Questionnaire. Path analysis was used to assess hypothesized mediators (ie, depression in the other parent, couple conflict, and paternal noninvolvement) of the associations between both paternal and maternal depression and child outcomes. We also tested for hypothesized moderators (ie, paternal education and antisocial traits). RESULTS: Family factors (maternal depression and couple conflict) mediated two-thirds of the overall association between paternal depression and child outcomes at 3.5 years. Similar findings were seen when children were 7 years old. In contrast, family factors mediated less than one-quarter of the association between maternal depression and child outcomes. There was no evidence of moderating effects of either parental education or antisocial traits. CONCLUSIONS: The majority of the association between depression in fathers postnatally and subsequent child behavior is explained by the mediating role of family environment, whereas the association between depression in mothers and child outcomes appears to be better explained by other factors, perhaps including direct mother-infant interaction.

Cortical abnormalities and their cognitive correlates in patients with temporal lobe epilepsy and interictal psychosis.

PURPOSE: To determine whether cortical abnormalities are more severe and widespread in patients with temporal lobe epilepsy (TLE) and interictal psychosis (IP) compared to those with TLE only (NIP) and healthy controls (HC), and to explore the associations between cortical parameters (area, thickness and volume), psychotic symptoms, and cognitive performance. METHODS: Twenty-two patients with IP (9 male; 10 hippocampal sclerosis, HS), 23 TLE nonpsychotic (NIP) patients (11 male; 13 HS) matched for duration of epilepsy and 20 HC participated. Surface-based morphometry (SBM) was used to measure cortical parameters. Cognition was examined in IP and NIP patients. Associations between cortical parameters and cognition were examined using linear mixed models adjusted by age, gender, and brain volume. KEY FINDINGS: IP patients had an earlier onset of epilepsy, more status epilepticus, and worse cognitive performance than NIP patients. In IP patients, cortical thickness was reduced in the inferior frontal gyrus (IFG), and their current IQ was associated with decreases in area, but not thickness, in regions of the frontotemporal cortex. SIGNIFICANCE: IP likely reflects the interplay of psychosis-related genetic factors and the cumulative effects of seizure activity on the brain. Cortical thinning in the IFG, a region implicated in schizophrenia, is likely to be related to seizure activity, whereas changes in IQ, associated with reductions in area of frontotemporal cortex, may be related to the presence of psychosis.

IQ and the fronto-temporal cortex in bipolar disorder.

Cognitive changes are documented in bipolar disorder (BP). Cortical volume loss, especially in prefrontal regions, has also been reported, but associations between cognition and cortical abnormalities have not been fully documented. This study explores associations between cognitive performance and cortical parameters (area, thickness and volume) of the fronto-temporal cortex in 36 BP patients (25 BPI and 11 BPII). T1-weighted volumetric MRI images were obtained using a 1.5 Tesla scanner. Cortical parameters were measured using surface-based morphometry and their associations with estimated premorbid, current IQ, visual memory, and executive function explored. Premorbid IQ was associated with frontal cortical area and volume, but no such associations were present for current cognitive performance. Cortical parameters were not different in BPI and BPII patients, but the association between current IQ and temporal cortical area was stronger in BPII patients. The pattern of cortico-cognitive associations in BPI and BPII patients merits further consideration.

[Background and findings of neuroimaging in schizophrenia: an update]. / Fundamentos y hallazgos de la neuroimagen en la esquizofrenia: una actualización.

INTRODUCTION: Neuroimaging of psychiatric disorders, especially on schizophrenia, has been increased in the last decade. Different brain imaging techniques have become a useful tool to discover the pathophysiology of schizophrenia. AIMS: To describe scientific and historical background of neuroimaging in psychiatry, and to describe the current structural, functional and neurochemical findings in schizophrenia using brain imaging techniques, and their potential disadvantages. DEVELOPMENT: This review synthesizes our current knowledge on the neurobiology of psychosis, reviewing studies including structural (magnetic resonance imaging, diffusion tensor imaging), functional (PET and SPECT, functional magnetic resonance imaging) and neurochemical/transmission (neurochemical PET and SPECT, magnetic resonance spectroscopy) neuroimaging techniques on schizophrenia. CONCLUSIONS: Cognitive impairment, structural and functional disturbances, dopaminergic hypothesis, white matter changes, and any other findings, have been reported. Nevertheless, there are still many doubts and discrepancies to solve, regarding to neuroimaging in schizophrenia. Coupling multimodal imaging with genetics and pharmacotherapeutic studies will further assist in understanding the pathophysiology of schizophrenia.

Fundamentos y hallazgos de la neuroimagen en la esquizofrenia: una actualización / Background and findings of neuroimaging in schizophrenia: an update

Introducción. La neuroimagen de los trastornos psiquiátricos, y en especial de la esquizofrenia, se ha incrementado en la última década. Las distintas modalidades de imagen cerebral se han convertido en una valiosa herramienta para investigar la fisiopatología de la esquizofrenia. Objetivos. Presentar los fundamentos científicos e históricos de la investigación con neuroimagen en psiquiatría y documentar los hallazgos estructurales, funcionales y bioquímicos de la esquizofrenia obtenidos mediante técnicas de neuroimagen, así como las posibles limitaciones que éstas presentan. Desarrollo. Este trabajo sintetiza el conocimiento actual de la neurobiología de la psicosis, mediante la revisión de estudios que incluyen técnicas de neuroimagen estructurales –resonancia magnética, imagen mediante tensor de difusión–, funcionales –tomografía computarizada por emisión de fotón único (SPECT) y tomografía por emisión de positrones (PET) de perfusión, resonancia magnética funcional– y bioquímicas o de transmisión –PET y SPECT de transmisión, espectroscopia por resonancia magnética– en la esquizofrenia. Conclusiones. Los estudios han confirmado los déficit cognitivos, las alteraciones estructurales y funcionales, la hipótesis dopaminérgica y las alteraciones en la sustancia blanca, entre otros muchos hallazgos; sin embargo, todavía quedan muchas dudas y discrepancias por resolver en cuanto a los hallazgos de la neuroimagen en la esquizofrenia. Ensamblar distintas técnicas de neuroimagen con estudios de genética y farmacoterapia permitiría obtener un conocimiento más amplio de la fisiopatología de la esquizofrenia (AU)

Introduction. Neuroimaging of psychiatric disorders, especially on schizophrenia, has been increased in the last decade. Different brain imaging techniques have become a useful tool to discover the pathophysiology of schizophrenia. Aims. To describe scientific and historical background of neuroimaging in psychiatry, and to describe the current structural, functional and neurochemical findings in schizophrenia using brain imaging techniques, and their potential disadvantages. Development. This review synthesizes our current knowledge on the neurobiology of psychosis, reviewing studies including structural (magnetic resonance imaging, diffusion tensor imaging), functional (PET and SPECT, functional magnetic resonance imaging) and neurochemical/transmission (neurochemical PET and SPECT, magnetic resonance spectroscopy) neuroimaging techniques on schizophrenia. Conclusions. Cognitive impairment, structural and functional disturbances, dopaminergic hypothesis, white matter changes, and any other findings, have been reported. Nevertheless, there are still many doubts and discrepancies to solve, regarding to neuroimaging in schizophrenia. Coupling multimodal imaging with genetics and pharmacotherapeutic studies will further assist in understanding the pathophysiology of schizophrenia (AU)

Retinal nerve fiber layer thickness measured byoptical coherence tomography in patients with schizophrenia: A short report

Background and Objectives: Our study aims to assess retinal nerve fiberlayer (RNFL) thickness in patients affected by schizophrenia. Methods: Ten schizophrenic (..) (AU)

Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis.

BACKGROUND: Loss of cortical volume in frontotemporal regions has been reported in patients with schizophrenia and their relatives. Cortical area and thickness are determined by different genetic processes, and measuring these parameters separately may clarify disturbances in corticogenesis relevant to schizophrenia. Our study also explored clinical and cognitive correlates of these parameters. METHODS: Thirty-seven patients with first-episode psychosis (34 schizophrenia, 3 schizoaffective disorder) and 38 healthy control subjects matched for age and sex took part in the study. Imaging was performed on an magnetic resonance imaging 1.5-T scanner. Area and thickness of the frontotemporal cortex were measured using a surface-based morphometry method (Freesurfer). All subjects underwent neuropsychologic testing that included measures of premorbid and current IQ, working and verbal memory, and executive function. RESULTS: Reductions in cortical area, more marked in the temporal cortex, were present in patients. Overall frontotemporal cortical thickness did not differ between groups, although regional thinning of the right superior temporal region was observed in patients. There was a significant association of both premorbid IQ and IQ at disease onset with area, but not thickness, of the frontotemporal cortex, and working memory span was associated with area of the frontal cortex. These associations remained significant when only patients with schizophrenia were considered. CONCLUSIONS: Our results suggest an early disruption of corticogenesis in schizophrenia, although the effect of subsequent environmental factors cannot be excluded. In addition, cortical abnormalities are subject to regional variations and differ from those present in neurodegenerative diseases.

Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.

BACKGROUND: Possession of one or more apolipoprotein E (APOE) epsilon4 alleles may influence the distribution of atrophy and clinical phenotype. We aimed to assess the influence of APOE genotype on cortical thickness and regional brain volumes in AD (Alzheimer's disease). METHODS: We included 38 patients (9 epsilon4 non-carriers, 23 epsilon4 heterozygotes, 6 epsilon4 homozygotes) and 23 controls. Each subject had 2 magnetic resonance imaging (MRI) scans and a neuropsychological battery. Cortical thickness and isthmus cingulate volume were measured using FreeSurfer; the volumes of the hippocampus, whole brain, and lateral ventricles were calculated using manual and semi-automated volumetry. RESULTS: Compared with controls, cortical thickness was significantly lower: in the bilateral temporal, posterior parietal and occipital regions in non-carriers, in the medial temporal and left parietal regions in heterozygotes, and in the medial temporal lobe in homozygotes. Comparisons between AD subgroups did not show significant differences. A trend for larger brain and isthmus cingulate volumes and smaller hippocampal and ventricular volumes with increasing epsilon4 dose were seen. These differences were supported by neuropsychological profiles. CONCLUSION: These results suggest that APOE genotype may influence the topography of regional atrophy and cortical thinning in AD.

A new autopsy interview for the assessment of factors potentially related to death in depressed medical patients.

This study tests the reliability and validity of the Bio-Psycho-Social Autopsy (BPSA), a new interview to assess physical, psychopathological, and social factors potentially related to mortality in depressed medical patients. The authors completed special procedures to provide support for the face and content validity of the interview. They built the psychopathological and social sections on the Standardized Polyvalent Psychiatric Interview (SPPI) but gave self-neglect special emphasis. They tested the BPSA on close relatives of 48 deceased patients, both depressed and nondepressed. They calculated interrater reliability coefficients and took preliminary steps to document the construct validity by means of epidemiological and clinical variables. Interrater reliability coefficients were acceptable (M kappa = 0.82). In support of the construct validity, a multivariate analysis showed that BPSA items in the psychopathological section were able to differentiate the expected direction between deceased patients who were depressed and nondepressed. Therefore, the authors considered the BPSA interview to be a reliable assessment of factors potentially associated with death in depressed medical patients, and data presented support the validity of the psychopathological section.